The bill’s provisions signify a substantial shift in state policy regarding sunscreen products. By requiring prescriptions for the sale of specific sunscreen ingredients, the law discourages their widespread use while aiming to protect coral reefs and other marine life from potential chemical exposure. This regulation aligns with a growing trend in Hawaii and other coastal states to enhance environmental protection and sustainability measures within the tourism and beauty industries.
Senate Bill 2850 proposes amendments to existing regulations concerning the sale and distribution of certain sunscreen products in Hawaii. The bill specifically prohibits the sale of sunscreens containing oxybenzone or octinoxate from January 1, 2021, unless prescribed by a licensed healthcare provider. Further, starting January 1, 2024, the bill extends this prohibition to sunscreens containing avobenzone or octocrylene. The aim of this legislation is to mitigate environmental impacts linked to these chemicals, which have been identified as harmful to marine ecosystems.
While the bill seeks to address environmental concerns, it has raised points of contention among stakeholders. Supporters argue that the health of Hawaii’s coral reefs necessitates strong legislative action, while critics express concerns over access and availability of sunscreen products to the public. There is apprehension that the requirement for a prescription could limit consumer options and undermine public health initiatives aimed at sun safety. Striking a balance between environmental protection and accessibility to safe skin care solutions is a key challenge highlighted in discussions surrounding SB2850.